Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial, Roche Products Pty Ltd, CON-867
Product name
ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial
Sponsor name
Roche Products Pty Ltd
Batches
1163406, 1164929, 1163292, 1163279, 1162729, 1163299, 1164608 and 1164287
Consent start
Consent no.
CON-867
Standard
Therapeutic Goods Order No. 91- Standard for labels of prescription and related medicines
Non-compliance with standard
The product does not conform to the requirements of Therapeutic Goods Order No.
91- Standard for labels of prescription and related medicines, in that the
product is labelled for clinical trial use only as per Annex 13 of the PIC/S
Guide to GMP (Investigational Medicinal Products) labelling requirements.
Conditions imposed
Information will be provided to the relevant healthcare professionals to confirm
the product supplied is identical to Australian registered Actemra product and
to explain the difference in product packaging compared to commercial product,
Therapeutic product type
Prescription medicines